Back to Global NewsPublished: 6 Mar 2026Download AppJoin TelegramWhy Tevogen's 17% Plunge May Signal a Hidden Upside for Generics Investors#Tevogen#Apozel Pharmaceuticals#Generics#Biotech M&A#NASDAQ#Pharma StocksDownload AppJoin CommunityShare Article